JPMorgan Chase Financial Co. LLC Files 424B2 Prospectus

TL;DR

**JPMorgan Chase Financial Co. LLC is gearing up to issue new securities, likely debt, to raise capital.**

AI Summary

JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co., filed a 424B2 prospectus on March 24, 2026, for an offering under its existing shelf registration (File No. 333-270004-01). This filing indicates that JPMorgan Chase Financial Co. LLC is preparing to issue new securities, likely debt, to raise capital. For investors, this means the company is actively managing its funding and could impact future earnings or dividend policies depending on the terms of the new securities.

Why It Matters

This filing signals JPMorgan Chase Financial Co. LLC's intent to raise capital, which could be used for general corporate purposes, refinancing debt, or funding new investments, potentially impacting the parent company's financial health and future stock performance.

Risk Assessment

Risk Level: low — This is a routine prospectus filing for a well-established financial institution, indicating standard capital-raising activities rather than an immediate high-risk event.

Analyst Insight

Investors should monitor subsequent filings (e.g., pricing supplements) to understand the specific terms, interest rates, and amounts of the securities being offered by JPMorgan Chase Financial Co. LLC, as these details will impact the company's financial leverage and cost of capital.

Key Numbers

• 2026-03-24 — Filing Date (Date the 424B2 prospectus was filed by JPMorgan Chase Financial Co. LLC)
• 333-270004-01 — File Number (Registration statement under which JPMorgan Chase Financial Co. LLC is offering securities)
• 0001665650 — CIK (Central Index Key for JPMorgan Chase Financial Co. LLC)
• 102331 — Document Size (bytes) (Size of the PRICING SUPPLEMENT document (ea0283259-01_424b2.htm))

Key Players & Entities

• JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus
• JPMORGAN CHASE & CO (company) — Parent company of the Filer
• 0001665650 (dollar_amount) — CIK of JPMorgan Chase Financial Co. LLC
• 2026-03-24 (dollar_amount) — Filing Date of the 424B2
• 333-270004-01 (dollar_amount) — File Number for JPMorgan Chase Financial Co. LLC's registration statement

Forward-Looking Statements

• JPMorgan Chase Financial Co. LLC will successfully issue new securities. (JPMorgan Chase Financial Co. LLC) — high confidence, target: 2026-06-30

FAQ

Key Financial Figures

• $6,049,000 — mpany LLC Medium-Term Notes, Series A $6,049,000 Capped Buffered Enhanced Participation
• $1,233.00 — ect to the maximum settlement amount of $1,233.00 for each $1,000 principal amount note.
• $1,000 — settlement amount of $1,233.00 for each $1,000 principal amount note. If the final und
• $977.20 — en the terms of the notes were set, was $977.20 per $1,000 principal amount note. See "
• $1,233.00 B — rlier level Maximum settlement amount: $1,233.00 Buffer level: 90.00% of the initial under
• $10,000 — and commissions, will be approximately $10,000. We have agreed to sell to JPMS, and JP

Filing Documents

• ea0283259-01_424b2.htm (424B2) — 100KB
• ea028325901_ex-filingfees.htm (EX-FILING FEES) — 4KB
• image_001.jpg (GRAPHIC) — 48KB
• image_002.jpg (GRAPHIC) — 39KB
• 0001213900-26-033516.txt ( ) — 315KB
• ea028325901_ex-filingfees_htm.xml (XML) — 2KB

From the Filing

SUPPLEMENT Filed Pursuant to Rule 424(b)(2) Registration Statement Nos. 333-270004 and 333-270004-01 Pricing Supplement to the Prospectus and Prospectus Supplement, each dated April 13, 2023 , the Underlying Supplement No. 1-I dated April 13, 2023 , the Product Supplement No. 4-I dated April 13, 2023 and the Prospectus Addendum dated June 3, 2024 JPMorgan Chase Financial Company LLC Medium-Term Notes, Series A $6,049,000 Capped Buffered Enhanced Participation Equity Notes due 2028 (Linked to the S&P 500 ® Index) Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. The notes do not bear interest. The amount that you will be paid on your notes on the stated maturity date (March 22, 2028, subject to adjustment) is based on the performance of the S&P 500 ® Index (which we refer to as the underlier) as measured from and including the trade date (March 20, 2026) to and including the determination date (March 20, 2028, subject to adjustment). If the final underlier level on the determination date is greater than the initial underlier level, the return on your notes will be positive, subject to the maximum settlement amount of $1,233.00 for each $1,000 principal amount note. If the final underlier level declines by up to 10.00% from the initial underlier level, you will receive the principal amount of your notes. If the final underlier level declines by more than 10.00% from the initial underlier level, the return on your notes will be negative. You could lose your entire investment in the notes. Any payment on the notes is subject to the credit risk of JPMorgan Chase Financial Company LLC ("JPMorgan Financial"), as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. To determine your payment at maturity, we will calculate the underlier return, which is the percentage increase or decrease in the final underlier level from the initial underlier level. On the stated maturity date, for each $1,000 principal amount note, you will receive an amount in cash equal to: if the underlier return is positive (the final underlier level is greater than the initial underlier level), the sum of (i) $1,000 plus (ii) the product of (a) $1,000 times (b) 2.00 times (c) the underlier return, subject to the maximum settlement amount; if the underlier return is zero or negative but not below -10.00% (the final underlier level is equal to or less than the initial underlier level but not by more than 10.00%), $1,000; or if the underlier return is negative and is below -10.00% (the final underlier level is less than the initial underlier level by more than 10.00%), the sum of (i) $1,000 plus (ii) the product of (a) $1,000 times (b) approximately 1.1111 times (c) the sum of the underlier return plus 10.00%. You will receive less than $1,000. Your investment in the notes involves certain risks, including, among other things, our credit risk. See "Risk Factors" on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" on page PS-11 of the accompanying product supplement and "Selected Risk Factors" on page PS-12 of this pricing supplement. The foregoing is only a brief summary of the terms of your notes. You should read the additional disclosure provided herein so that you may better understand the terms and risks of your investment. The estimated value of the notes, when the terms of the notes were set, was $977.20 per $1,000 principal amount note. See "Summary Information — The Estimated Value of the Notes" on page PS-6 of this pricing supplement for additional information about the estimated value of the notes and "Summary Information — Secondary Market Prices of the Notes" on page PS-7 of this pricing supplement for information about secondary market prices of the notes. Original issue date (settlement date): March 25, 2026 Original issue price: 100.00% of the principal amount Underwriting commission/discount: 2.00% of the principal amount* Net proceeds to the issuer: 98.00% of the principal amount See "Summary Information — Supplemental Use of Proceeds" on page PS-8 of this pricing supplement for information about the components of the original issue price of the notes. *J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of 2.00% of the principal amount it receives from us to an unaffiliated dealer. See "Plan of Distribution (Conflicts of Interest)" on page PS-86 of the accompanying product supplement. Neither the Securities and Exchange Commission (the "SEC") nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this pricing supplement, the accompanying product supplement, the accompanying underlying supplement, the accompanying prospectus supplement, the accompanying prospectus or the accompanying prospectus addendum. Any representation to

View Full Filing

View this 424B2 filing on SEC EDGAR